Bruce Booth
QuietNamed in filings at Atlas VentureOn the current fund
- Board seats filed
- 11
Named in filings at Atlas VentureOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Matchpoint Therapeutics | Biotech & pharma | October 2022 | None on file |
| Vigil Neuroscience | Biotech & pharma | September 2020 | Hatteras Venture Partners, Vida Ventures |
| MIRAGEN THERAPEUTICS | Biotech & pharma | November 2017 | None on file |
| Rodin Therapeutics | Biotech & pharma | August 2017 | None on file |
| Magenta Therapeutics | Biotech & pharma | November 2016 | None on file |
| AVROBIO | Biotech & pharma | July 2016 | Clarus |
| Lysosomal Therapeutics | Biotech & pharma | January 2015 | Hatteras Venture Partners |
| Unum Therapeutics | Biotech & pharma | October 2014 | New Leaf |
| NUMERATE | Biotech & pharma | May 2014 | None on file |
| On-Q-ity | Biotech & pharma | February 2012 | Bessemer Venture Partners |
| Miragen Therapeutics | Biotech & pharma | September 2010 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Bruce Booth on the board, based on 11 filed seats with a verified or cited source.